| SHOCKWAVE MEDICAL, INC. | |||||||||||||||||
| Statement of Operations Data | |||||||||||||||||
| (Unaudited) | |||||||||||||||||
| (in thousands, except share and per share data) | |||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, | ||||||||||||||||
| 2019 | 2018 | 2019 | 2018 | ||||||||||||||
| Revenue: | |||||||||||||||||
| Product revenue | $ | 11,333 | $ | 3,600 | $ | 28,615 | $ | 7,201 | |||||||||
| Operating expenses: | |||||||||||||||||
| Cost of product revenue | 4,401 | 1,973 | 11,606 | 3,946 | |||||||||||||
| Research and development | 8,368 | 5,533 | 22,778 | 16,579 | |||||||||||||
| Sales and marketing | 8,192 | 4,801 | 21,023 | 12,611 | |||||||||||||
| General and administrative | 3,437 | 1,369 | 9,684 | 4,137 | |||||||||||||
| Total operating expenses | 24,398 | 13,676 | 65,091 | 37,273 | |||||||||||||
| Loss from operations | (13,065 | ) | (10,076 | ) | (36,476 | ) | (30,072 | ) | |||||||||
| Interest expense | (251 | ) | (158 | ) | (746 | ) | (216 | ) | |||||||||
| Change in fair value of warrant liability | — | (104 | ) | (609 | ) | (53 | ) | ||||||||||
| Other income, net | 385 | 166 | 1,518 | 489 | |||||||||||||
| Net loss before taxes | (12,931 | ) | (10,172 | ) | (36,313 | ) | (29,852 | ) | |||||||||
| Income tax provision | 26 | 6 | 51 | 27 | |||||||||||||
| Net loss | $ | (12,957 | ) | $ | (10,178 | ) | $ | (36,364 | ) | $ | (29,879 | ) | |||||
| Net loss per share, basic and diluted | $ | (0.46 | ) | $ | (5.73 | ) | $ | (1.66 | ) | $ | (17.15 | ) | |||||
| Shares used in computing net loss per share, basic and diluted | 28,085,821 | 1,776,249 | 21,886,396 | 1,742,572 | |||||||||||||
« Previous Page 1 | 2
